MCAF5352A

· Genentech, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for MCAF5352A, covering 2016-11-02 to 2016-11-02. Get the full timeline:

Most recent: Clinical Trial Update: Study to Investigate the Safety, Pharmacokinetics, and Immunogenicity of Subcutaneous MCAF5352A in Healthy Volunteers [Phase 1]

See pricing